echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur J Cancer: Thinking carefully, terrifying!

    Eur J Cancer: Thinking carefully, terrifying!

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the past 20 years, about a proton pump inhibitor (PPI) is causing digestive argue that the tumor continues


    Digestion

    This study is a systematic review and meta-analysis, using the Bradford Hill criteria of causality comprehensive assessment of the PPI to digest the impact tract cancer risk


    Digestion

    The researchers searched the Medline, Embase, and Web of Science databases for observational studies published before January 15, 2021


    PPI use andCorrelation of gastric cancer (A), esophageal cancer (B), colorectal cancer (C) and pancreatic cancer (D) risk

    PPI use andCorrelation of gastric cancer (A), esophageal cancer (B), colorectal cancer (C) and pancreatic cancer (D) riskGastric cancer colorectal cancer pancreatic cancer

    A total of 32 studies were screened, containing 4,355,254 subjects


    The use of PPI is associated with an increased overall risk of gastrointestinal cancer.


    The relationship between PPI use reaching a limited dose or prolonged duration and the risk of gastrointestinal cancer

    The relationship between PPI use reaching a limited dose or prolonged duration and the risk of gastrointestinal cancer

    The correlation between PPI use and gastrointestinal cancer is more pronounced in the population with the lowest PPI exposure


    In summary, the use of PPI is associated with an increased risk of some gastrointestinal cancers .


    The use of PPI is associated with an increased risk of gastrointestinal cancer .


    Original source:

    Zeng Ruijie,Cheng Yunjiu,Luo Dongling et al.


    Comprehensive analyis of proton pump inhibitors and risk of digestive tract cancers

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.